VA

The study's findings could also point to potential treatment candidates for post-traumatic stress disorder, the researchers said.

The company said its Professional PGx Express test will now be reimbursed by Medicare, and that the VA has extended its current supply contract for the test.

Oppenheimer downgraded the company's shares to Perform from Outperform on Friday, based on valuation and expected headwinds from the pandemic.

With single-cell transcriptomic, T cell receptor, and B cell receptor data, researchers tracked immune shifts in tissue and peripheral blood samples from ulcerative colitis patients.

The company's Q2 revenue growth was driven by a 74 percent increase in revenues from the analytical services it provided to the VA MVP program.

The company said Q1 revenue growth was driven by an increase in testing volume and analytical services provided to the US Department of Veterans Affairs.

A genome-wide association study involving some 200,000 veterans unearthed five anxiety risk loci in European Americans and another risk locus in African Americans.

The company attributed much of the increase to its work with the VA’s Million Veteran Program, which made up three quarters of its earnings in the quarter.

The search uncovered two post-traumatic stress disorder loci in Europeans and a third in individuals with African ancestry, highlighting immune- and brain-related genes.